Use of mPEG-PLGA nanoparticles to improve bioactivity and hemocompatibility of streptokinase: In-vitro and in-vivo studies
Authors:
- 1 January 2021
- journal article
- research article
- Published by Elsevier in Materials Science and Engineering: C
- Vol. 118, 111427
Abstract
No abstract availableKeywords
Funding Information
- Tehran University of Medical Sciences and Health Services
This publication has 45 references indexed in Scilit:
- Effects of Particle Size and Surface Modification on Cellular Uptake and Biodistribution of Polymeric Nanoparticles for Drug DeliveryPharmaceutical Research, 2013
- Polycation-siRNA nanoparticles can disassemble at the kidney glomerular basement membraneProceedings of the National Academy of Sciences, 2012
- Emerging role of radiolabeled nanoparticles as an effective diagnostic techniqueEJNMMI Research, 2012
- Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery CarrierPolymers, 2011
- Porous PLGA Microspheres Effectively Loaded with BSA Protein by Electrospraying Combined with Phase Separation in Liquid NitrogenJournal of Biomimetics, Biomaterials and Tissue Engineering, 2010
- Nanoparticles in cellular drug deliveryBioorganic & Medicinal Chemistry, 2009
- Factors Affecting the Clearance and Biodistribution of Polymeric NanoparticlesMolecular Pharmaceutics, 2008
- Synthesis, Characterization, and in Vitro Activity of Dendrimer−Streptokinase ConjugatesBioconjugate Chemistry, 2007
- The use of glycolipids and hydrophilic polymers in avoiding rapid uptake of liposomes by the mononuclear phagocyte systemAdvanced Drug Delivery Reviews, 1994
- Streptokinase in the management of arterial thrombosis in infancyInternational Journal of Cardiology, 1989